Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kanebo is a historic Japanese company that was once a leading conglomerate in the pharmaceutical, cosmetic, and textile sectors. Following a significant financial restructuring in the mid-2000s, the company's operations were split; the cosmetics division was acquired by Kao Corporation, while the pharmaceutical and consumer goods divisions were rebranded as Kracie. In the life sciences space, Kanebo was renowned for its extensive portfolio of Kampo (traditional Japanese herbal) medicines and over-the-counter healthcare products. Today, the Kanebo brand continues to operate as a major subsidiary of Kao, focusing on high-end skincare and beauty technology. The pharmaceutical legacy continues under Kracie Pharma, which remains a dominant player in the Japanese herbal medicine market. The company's historical contributions to dermatology and botanical research remain influential in the Japanese healthcare landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kanebo.